A detailed history of Triune Financial Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Triune Financial Partners, LLC holds 1,169 shares of DHR stock, worth $270,155. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,169
Holding current value
$270,155
% of portfolio
0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$239.25 - $280.76 $279,683 - $328,208
1,169 New
1,169 $325 Million
Q2 2024

Nov 05, 2024

SELL
$235.51 - $267.98 $471 - $535
-2 Reduced 0.17%
1,167 $292 Million
Q1 2024

Nov 14, 2024

SELL
$224.58 - $256.19 $2,021 - $2,305
-9 Reduced 0.78%
1,151 $287 Million
Q4 2023

Nov 14, 2024

BUY
$185.1 - $233.13 $1,851 - $2,331
10 Added 0.87%
1,160 $268 Million
Q3 2023

Nov 14, 2024

SELL
$233.08 - $265.59 $4,428 - $5,046
-19 Reduced 1.63%
1,150 $285 Million
Q2 2023

Dec 06, 2024

BUY
$224.99 - $256.14 $224 - $256
1 Added 0.09%
1,149 $276 Million
Q1 2023

Dec 06, 2024

SELL
$239.75 - $277.0 $5,034 - $5,817
-21 Reduced 1.8%
1,148 $289 Million
Q4 2022

Dec 06, 2024

BUY
$241.42 - $282.29 $241 - $282
1 Added 0.09%
1,147 $304 Million
Q3 2022

Dec 06, 2024

BUY
$247.06 - $1507.4 $247 - $1,507
1 Added 0.09%
1,146 $296 Million
Q2 2022

Dec 06, 2024

BUY
$237.11 - $299.66 $237 - $299
1 Added 0.09%
1,145 $290 Million
Q1 2022

Dec 06, 2024

SELL
$257.27 - $315.76 $6,431 - $7,894
-25 Reduced 2.14%
1,144 $335 Million
Q4 2021

Dec 06, 2024

BUY
$292.08 - $329.01 $584 - $658
2 Added 0.18%
1,143 $376 Million
Q2 2021

Dec 06, 2024

SELL
$225.08 - $271.69 $6,302 - $7,607
-28 Reduced 2.4%
1,141 $306 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Triune Financial Partners, LLC Portfolio

Follow Triune Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triune Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Triune Financial Partners, LLC with notifications on news.